MedPath
NMPA Approval

Ebastine Oral Solution

国药准字H20253789

April 1, 2025

Drug Information

依巴斯汀口服溶液

口服溶液剂

120ml:120mg

化学药品

April 1, 2025

Company Information

Applicant Company

海南省海口市国家高新技术产业开发区科技大道22号海口国科中心B栋702室

Manufacturing Company

成都天府国际生物城(双流区乐康路9号)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

依巴斯汀口服溶液 - NMPA 批准文号 | MedPath